Health

Makowka will manage relationships with AHA Ventures portfolio companies.

GCV has looked through our data to find the busiest investors in corporate venture capital. Here's how and where they invested in 2024.

Large life sciences deals and corporate investors buying the companies in their own portfolio have been key to an improving exit market.

AI funding rounds commanded huge prices in 2024, but corporate investors also made large bets in healthcare, energy and robotics.

Many of the companies have financial and corporate venture backers, as businesses seek alternatives to single-use plastics.

King worked at Intel's corporate venturing arm before joining the investment arm of the newly listed healthcare company.

University venture funds are becoming an increasingly important tool for universities to support their ecosystems — here are the new ones launched in 2024.

More than 60% of CVC units survive beyond their initial 3 years. Those that close do so for a variety of reasons — here's a look at five that ceased operations this year.

Rounds are getting bigger and investors want to see more earlier, but the distinction between them is still important.

With billion-dollar funding rounds being limited to a few large companies, the self-driving car industry still appears to have a bumpy road ahead.

The UK stands to benefit from the work of the past 12 months to push more university research-led innovation into the marketplace.